XML 33 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 16 - Segment and Geographic Information
 9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
16.
Segment and Geographic Information
 
The Company has
one
reportable operating segment for the purposes of assessing performance and determining the allocation of resources.
 
Product revenue by product group is as follows:
 
    Three Months Ended September 30,   Nine Months Ended September 30,
    2017   2016   2017   2016
Orthobiologics   $
23,990
     $
22,428
     $
68,686
     $
65,319
  
Surgical    
1,765
      
1,173
      
4,395
      
3,924
  
Dermal    
358
      
594
      
1,235
      
1,558
  
Other    
1,065
      
1,588
      
4,583
      
3,835
  
Product Revenue   $
27,178
     $
25,783
     $
78,899
     $
74,636
  
 
Total revenue by geographic location and as a percentage of overall total revenue for the
three
- and
nine
-month periods ended
September 30, 2017
and
2016
are as follows:
 
    Three Months Ended September 30,
    2017   2016
    Total
Revenue		   Percentage of
Revenue		   Total
Revenue		   Percentage of
Revenue
Geographic Location:                                
United States   $
22,227
      
82
 %   $
21,126
      
82
 %
Europe    
2,832
      
10
 %    
2,703
      
10
 %
Other    
2,125
      
8
 %    
1,960
      
8
 %
Total Revenue   $
27,184
      
100
 %   $
25,789
      
100
 %
 
    Nine Months Ended September 30,
    2017   2016
    Total
Revenue		   Percentage of
Revenue		   Total
Revenue		   Percentage of
Revenue
Geographic Location:                                
United States   $
68,624
      
82
 %   $
61,032
      
82
 %
Europe    
9,743
      
11
 %    
8,240
      
11
 %
Other    
5,665
      
7
 %    
5,381
      
7
 %
Total Revenue   $
84,032
      
100
 %   $
74,653
      
100
 %